MedPath

Comparison Between Patching and Interactive Binocular Treatment (IBiTTM) in Amblyopia

Not Applicable
Conditions
The New Treatment in Amblyopia Therapy
Interventions
Device: Interactive Binocular Treatment
Procedure: Patching Therapy
Registration Number
NCT03940222
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

The purpose of this study is to investigate the effect of amblyopia therapy on cases who will receive Interactive Binocular Treatment (IBiTTM) without patching compared with those who will receive standard patching of the dominant eye with placebo IBiTTM.

In this randomized clinical trial, 40 unilateral amblyopic children (3 to 10 years old) will be studied. All unilateral functional amblyopic children with best corrected visual acuity (BCVA) worse than 0.30 LogMAR at least in one eye or a difference of two BCVA lines of Snellen between the two eyes will be included and randomly will divide into the case (n=19) and control (n=21) groups. Cases will play I-BiT™ games, while controls will have standard patch therapy and will play with placebo IBiTTM for one month. All subjects will be underwent comprehensive ophthalmic examinations at baseline and at one-month follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Functional amblyopia with BCVA less than 20/30 (0.3 LogMAR) at least in one eye
  • A difference of two BCVA lines of Snellen between the two eyes
Exclusion Criteria
  • A history of penalization one month prior to the study
  • Bilateral amblyopia
  • BCVA less than 20/200
  • Eccentric fixation
  • Nystagmus
  • Ocular deviation more than 10 prism diopter (pd)
  • Organic amblyopia
  • Uncooperative children those with
  • Mental and physical disability
  • Systemic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
I-BiT groupInteractive Binocular TreatmentAmblyopic patients will play I-BiT games without patching.
Placebo groupPatching TherapyAmblyopic patients will patch their dominant eye and they will play placebo I-BiT games.
Primary Outcome Measures
NameTimeMethod
Best Corrected Visual Acuity6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hamideh Sabbaghi

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath